Commentary: Time to make moves on opioid prescribing following cardiac surgery

J Thorac Cardiovasc Surg. 2020 Oct;160(4):966-967. doi: 10.1016/j.jtcvs.2019.10.018. Epub 2019 Oct 16.

Authors

Kimberly A Holst¹, Elizabeth B Habermann²

Affiliations

¹ Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn. Electronic address: holst.kimberly1@mayo.edu.
² Department of Health Services Research, Mayo Clinic, Rochester, Minn.

PMID: 31898959
DOI: 10.1016/j.jtcvs.2019.10.018

No abstract available

Publication types

Editorial
Comment

MeSH terms

Analgesics, Opioid / adverse effects
Cardiac Surgical Procedures* / adverse effects
Coronary Artery Bypass
Humans
Opioid-Related Disorders* / epidemiology
Opioid-Related Disorders* / prevention & control
Pain, Postoperative / etiology
Pain, Postoperative / prevention & control
Practice Patterns, Physicians'

Substances

Analgesics, Opioid